Physio-Control, Inc., a global leader in emergency medical solutions and
wholly‐owned subsidiary of Medtronic, Inc., MDT, today announced
commercial availability of the ReadyLink 12-Lead ECG device, a new, U.S. Food
and Drug Administration cleared solution designed to improve care
for heart attack patients and expand regional STEMI systems.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in